Öztürk, YusufTopal, ZehraDemir, NuranTufan, Ali Evren2021-06-232021-06-2320182090-50682090-5076https://doi.org/10.1016/j.ajme.2017.08.008https://hdl.handle.net/20.500.12491/9482Informed consent in clinical practice is a process in which a patient consents to participate or undergo the proposed procedures after being informed of its procedures, risks, and benefits. Ideally, the patient is expected to give his/her consent solely after fully understanding the information about the procedures, benefits, and risks involved in the practice. According to the doctrine, the necessary information should be given by the physician and he/she should also respect the decision of the patient which is based on this information.1 Although the importance of providinginformation about the proposed treatment’s effects and side effects to children and adolescents before treatment is accepted by physicians, this issue is given little importance in research and case presentations.2 In this case, it was aimed to discuss the importance of informed consent and multi-disciplinary approach in treatment by presenting an adolescent patient who was diagnosed with palatal myoclonus and treated with botulinum toxin. Although the neurological treatment was effective, the patient developed adjustment disorder (with depressive mood) due to dysphonia after the procedure.eninfo:eu-repo/semantics/openAccessAdolescent Palatal MyoclonusBotulinum Toxin InjectionNeuropsychiatric DisordersCase Report10.1016/j.ajme.2017.08.008544365366WOS:000450928200017N/A